Surgery is the only way to fully remove a nasal polyp, but they can still regrow. Prescription nasal sprays and oral medications can help to shrink nasal polyps without the need for surgery. Nasal ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of ...

Nasal polyps are noncancerous growths that can form in the nasal cavity. Although benign, they can have a significant impact on a person’s quality of life. Nasal polyps often occur along with ...

While nasal polyps often return after surgical removal, knowing your options can help keep symptoms at bay. Nasal polyps are noncancerous (benign) growths that develop in the nose. They are seen in ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Laurimed LLC today announced that the company’s PolypVac ® Microdebrider for removing nasal polyps has appeared on the popular television program “The Doctors”, ...

GSK plc (LSE/NYSE:GSK) announced Monday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Exdensur (depemokimab) as an add-on maintenance ...

Nasal polyps are small noncancerous growths in the nose or sinuses. They may cause pain or pressure in the face, runny or stuffy nose, and other symptoms or complications that may negatively affect ...

Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

Nasal polyps are common, noncancerous, teardrop-shaped growths that form in your nose or sinuses. They’re usually found around the area where the sinuses open into the nasal cavity. Mature ones look ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps to include adolescents as well, Regeneron Pharmaceuticals and Sanofi ...